419 related articles for article (PubMed ID: 18824610)
21. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
[TBL] [Abstract][Full Text] [Related]
22. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae.
Haimeur A; Brochu C; Genest P; Papadopoulou B; Ouellette M
Mol Biochem Parasitol; 2000 Apr; 108(1):131-5. PubMed ID: 10802326
[No Abstract] [Full Text] [Related]
23. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
[TBL] [Abstract][Full Text] [Related]
24. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
[TBL] [Abstract][Full Text] [Related]
25. In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.
da Luz RI; Vermeersch M; Dujardin JC; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Dec; 53(12):5197-203. PubMed ID: 19752271
[TBL] [Abstract][Full Text] [Related]
26. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.
El Fadili K; Messier N; Leprohon P; Roy G; Guimond C; Trudel N; Saravia NG; Papadopoulou B; Légaré D; Ouellette M
Antimicrob Agents Chemother; 2005 May; 49(5):1988-93. PubMed ID: 15855523
[TBL] [Abstract][Full Text] [Related]
27. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru.
Adaui V; Maes I; Huyse T; Van den Broeck F; Talledo M; Kuhls K; De Doncker S; Maes L; Llanos-Cuentas A; Schönian G; Arevalo J; Dujardin JC
Infect Genet Evol; 2011 Dec; 11(8):1873-80. PubMed ID: 21871584
[TBL] [Abstract][Full Text] [Related]
28. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
Gomes ML; DeFreitas-Silva G; dos Reis PG; Melo MN; Frézard F; Demicheli C; Idemori YM
J Biol Inorg Chem; 2015 Jul; 20(5):771-9. PubMed ID: 25929728
[TBL] [Abstract][Full Text] [Related]
30. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of nicotinamide/antileishmanial drug combinations.
Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
[TBL] [Abstract][Full Text] [Related]
32. Speciation analysis of Sb(III) and Sb(V) in antileishmaniotic drug using Dowex 1 x 4 resin from hydrochloric acid solution.
Łukaszczyk L; Zyrnicki W
J Pharm Biomed Anal; 2010 Sep; 52(5):747-51. PubMed ID: 20207516
[TBL] [Abstract][Full Text] [Related]
33. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
[TBL] [Abstract][Full Text] [Related]
34. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
[TBL] [Abstract][Full Text] [Related]
35. ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.
Arcari T; Manzano JI; Gamarro F
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971869
[TBL] [Abstract][Full Text] [Related]
36. Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts.
Chai Y; Yan S; Wong IL; Chow LM; Sun H
J Inorg Biochem; 2005 Dec; 99(12):2257-63. PubMed ID: 16214217
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony.
Medina J; Cruz-Saavedra L; Patiño LH; Muñoz M; Ramírez JD
Parasit Vectors; 2021 Aug; 14(1):419. PubMed ID: 34419127
[TBL] [Abstract][Full Text] [Related]
38. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony.
Adaui V; Schnorbusch K; Zimic M; Gutiérrez A; Decuypere S; Vanaerschot M; DE Doncker S; Maes I; Llanos-Cuentas A; Chappuis F; Arévalo J; Dujardin JC
Parasitology; 2011 Feb; 138(2):183-93. PubMed ID: 20678296
[TBL] [Abstract][Full Text] [Related]
39. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.
Wyllie S; Cunningham ML; Fairlamb AH
J Biol Chem; 2004 Sep; 279(38):39925-32. PubMed ID: 15252045
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
Berman JD; Chulay JD; Hendricks LD; Oster CN
Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
